Also, patients should be warned about the danger of taking folic acid in place of Vitamin B12, because the former may prevent anemia but allow progression of subacute combined degeneration
This is possibly due to overlapping anti-hyperglycemic mechanisms shared by both cagrilintide and semaglutide such as delay in gastric emptying and inhibition of postprandial glucagon secretion
& Sooriakumaran, P
Comment: In response to our concern that the Axoguard HA+ Nerve Protector TM may be appropriately described by C1763 and C1765, the applicant commented that although the Axoguard HA+ Nerve Protector TM , on a superficial level, shares some attributes with products billed to those HCPCS codes, the existing codes were established for different materials and clinical uses, and thus, do not accurately describe the nominated device or its intended application
All claims can be submitted by email to [email protected]
Knerr, P.J., Mowery, S.A., Finan, B., Perez-Tilve, D., Tschp, M.H., DiMarchi, R.D